Table 4.
Study | Type of Study | Treatment | Post-Treatment Marker’s Level | Source | p-Value |
---|---|---|---|---|---|
Chabre et al., 2013 [35] | Clinical | Surgical removal | ↓ miR-483-5p, ↑ miR-195 | Serum | <0.05 |
Nagy et al., 2015 [42] | In vivo: Patient-derived xenograft in mice | Combined 9-cis retinoic acid + mitotane treatment. |
↓ miR-483-5p | Serum | 0.028 |
Jung et al., 2016 [43] | In vivo: SW-13 xenograft | LEDP-M treatment | ↓ miR-210 | Serum | <0.05 |
Upwards arrows (↑) indicate upregulation and downwards arrows (↓) indicate downregulation of miRNAs. Abbreviations: LEDP-M, etoposide, liposomal doxorubicin, liposomal cisplatin, mitotane.